Publisher Correction: Repurposing raltegravir for reducing inflammation and treating cancer: a bioinformatics analysis. [PDF]
Nikfarjam Z+5 more
europepmc +1 more source
Repurposing raltegravir for reducing inflammation and treating cancer: a bioinformatics analysis. [PDF]
Nikfarjam Z+5 more
europepmc +1 more source
Drug-Drug Interactions Between Raltegravir and Pravastatin in Healthy Volunteers
Matthijs van Luin+7 more
openalex +1 more source
Brief communication: characteristics of primary drug resistance in newly diagnosed HIV-infected individuals in Ganzhou, China. [PDF]
Huang DD+6 more
europepmc +1 more source
Pharmacokinetics of Abacavir and its Anabolite Carbovir Triphosphate without and with Darunavir/ Ritonavir or Raltegravir in HIV-Infected Subjects [PDF]
Akil Jackson+9 more
openalex +1 more source
Alternaria alternata (Fr) Keissl Crude Extract Inhibits HIV Subtypes and Integrase Drug-Resistant Strains at Different Stages of HIV Replication. [PDF]
Naidu D+4 more
europepmc +1 more source
Safety and efficacy of raltegravir in patients with HIV‐1 and hepatitis B and/or C virus coinfection [PDF]
JK Rockstroh+7 more
openalex +1 more source
Preswitch Regimens Associated With Weight Gain Among Persons With HIV who Switch to Integrase Inhibitor-Containing Regimens. [PDF]
Cutshaw MK+3 more
europepmc +1 more source
HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations in ART-Naïve Individuals in South Korea from 2021 to 2024. [PDF]
Kim G+6 more
europepmc +1 more source